Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: A case report.

Takei D, Abe T, Amano H, Hirano N, Kobayashi T, Ohdan H, Kondo T, Nakahara M, Noriyuki T.

Int J Surg Case Rep. 2017;31:5-9. doi: 10.1016/j.ijscr.2016.12.012. Epub 2016 Dec 21.

PMID:
28076752
2.

The diagnostic maze of synchronous mass lesions in brain and lung.

Aung T, Ford D, Hardmann M, Hingorani M.

Med J Armed Forces India. 2016 Dec;72(Suppl 1):S153-S156. doi: 10.1016/j.mjafi.2016.03.002. Epub 2016 May 26. No abstract available.

PMID:
28050100
3.

The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).

Watanabe S, Manabe O, Hirata K, Oyama-Manabe N, Hattori N, Kikuchi Y, Kobayashi K, Toyonaga T, Tamaki N.

BMC Cancer. 2016 Aug 15;16:635. doi: 10.1186/s12885-016-2672-8.

PMID:
27528380
4.

Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?

Yadlapati S, Efthimiou P.

Biomed Res Int. 2016;2016:8631061. doi: 10.1155/2016/8631061. Epub 2016 Jun 27. Review.

PMID:
27429984
5.

Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.

Ikeda K, Nakamura T, Kinoshita T, Fujiwara M, Uose S, Someda H, Miyoshi T, Io K, Nagai K.

Clin J Gastroenterol. 2016 Feb;9(1):17-21. doi: 10.1007/s12328-015-0624-5. Epub 2016 Jan 5.

PMID:
26733461
6.

Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders.

Lam GY, Halloran BP, Peters AC, Fedorak RN.

World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):181-92. doi: 10.4291/wjgp.v6.i4.181. Review.

PMID:
26600976
7.

Primary Adrenal Lymphoma Possibly Associated With Epstein-Barr Virus Reactivation Due to Immunosuppression Under Methotrexate Therapy.

Ohkura Y, Shindoh J, Haruta S, Kaji D, Ota Y, Fujii T, Hashimoto M, Watanabe G, Matsuda M.

Medicine (Baltimore). 2015 Aug;94(31):e1270. doi: 10.1097/MD.0000000000001270.

PMID:
26252293
8.

A case of spontaneous regression of pulmonary mucosa-associated lymphoid tissue (MALT) type lymphoma with Sjögren's syndrome treated with methotrexate for rheumatoid arthritis.

Yasui H, Nakamura Y, Hasegawa H, Fujisawa T, Enomoto N, Inui N, Fukuoka J, Suda T.

Respir Med Case Rep. 2015 Mar 3;15:4-6. doi: 10.1016/j.rmcr.2015.02.008. eCollection 2015.

PMID:
26236588
9.

Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma.

Kawahara A, Tsukada J, Yamaguchi T, Katsuragi T, Higashi T.

Biomark Res. 2015 May 6;3:10. doi: 10.1186/s40364-015-0035-2. eCollection 2015.

PMID:
25964853
10.

Primary central nervous system lymphoma in a rheumatoid arthritis patient treated with methotrexate: a case report.

Shimada H, Dobashi H, Morimoto H, Kameda T, Susaki K, Izumikawa M, Takeuchi Y, Nakashima S, Imataki O, Bandoh S.

BMC Res Notes. 2015 Mar 19;8:88. doi: 10.1186/s13104-015-1040-0.

PMID:
25888766
11.

Primary hepatic lymphoma in a patient with rheumatoid arthritis treated with methotrexate.

Tatsumi G, Ukyo N, Hirata H, Tsudo M.

Case Rep Hematol. 2014;2014:460574. doi: 10.1155/2014/460574. Epub 2014 Dec 24.

PMID:
25610674
12.

The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study.

Wu CY, Chen DY, Shen JL, Ho HJ, Chen CC, Kuo KN, Liu HN, Chang YT, Chen YJ.

Arthritis Res Ther. 2014 Sep 30;16(5):449. doi: 10.1186/s13075-014-0449-5. Erratum in: Arthritis Res Ther. 2016;18(1):110.

PMID:
25267341
13.

Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.

Nakanishi R, Ishida M, Hodohara K, Okuno H, Yoshii M, Horinouchi A, Shirakawa A, Harada A, Iwai M, Yoshida K, Kagotani A, Yoshida T, Okabe H.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1748-54. eCollection 2014. Review.

PMID:
24817974
14.

Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report.

Kuroda T, Sato H, Nakatsue T, Wada Y, Murakami S, Nakano M, Narita I.

BMC Res Notes. 2014 Apr 11;7:229. doi: 10.1186/1756-0500-7-229.

PMID:
24721419
15.

A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort.

Gross RL, Schwartzman-Morris JS, Krathen M, Reed G, Chang H, Saunders KC, Fisher MC, Greenberg JD, Putterman C, Mease PJ, Gottlieb AB, Kremer JM, Broder A.

Arthritis Rheumatol. 2014 Jun;66(6):1472-81. doi: 10.1002/art.38385.

PMID:
24591475
16.

Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.

Ishida M, Hodohara K, Yoshii M, Okuno H, Horinouchi A, Nakanishi R, Harada A, Iwai M, Yoshida K, Kagotani A, Yoshida T, Okabe H.

Int J Clin Exp Pathol. 2013 Sep 15;6(10):2237-41. eCollection 2013.

PMID:
24133604
17.

Immune surveillance and lymphoid malignancy in immunocompromised host.

Stevens PL, Reddy NM.

Am J Blood Res. 2013 May 5;3(2):91-101. Print 2013.

PMID:
23675561
18.

Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration.

Takemori N, Kaneko H, Nakamura M, Kojima M.

Case Rep Hematol. 2012;2012:658745. doi: 10.1155/2012/658745. Epub 2012 Dec 19.

PMID:
23316401
19.

Lymphoproliferative disorder due to sulphasalazine.

Dubey S, Adebajo AO.

BMJ Case Rep. 2009;2009. pii: bcr06.2008.0038. doi: 10.1136/bcr.06.2008.0038. Epub 2009 Mar 17.

PMID:
21686950
20.

Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune disease.

Landgren O, Pfeiffer RM, Kristinsson SY, Björkholm M.

J Clin Oncol. 2010 Dec 1;28(34):5081-7. doi: 10.1200/JCO.2010.29.2243. Epub 2010 Oct 12.

PMID:
20940191

Supplemental Content

Support Center